Comprehensive Insight on the Scleroderma Drug Pipeline Landscape Revealed in the Latest 2024 Report
22 nov. 2024 06h56 HE
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Scleroderma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The Scleroderma drug pipeline report for 2024 has...
Scleroderma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising a Broad Spectrum of Molecular Targets
22 sept. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Scleroderma Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising a Broad Spectrum of Molecular Targets There are...